<?xml version="1.0" encoding="UTF-8"?>
<ref id="B199-pathogens-09-00856">
 <label>199.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Qu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Donkers</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>van de Graaf</surname>
    <given-names>S.F.J.</given-names>
   </name>
   <name>
    <surname>de Man</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Peppelenbosch</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Pan</surname>
    <given-names>Q.</given-names>
   </name>
  </person-group>
  <article-title>FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-ÎºB-RIPK1-caspase axis</article-title>
  <source>Antiviral Res.</source>
  <year>2019</year>
  <volume>170</volume>
  <fpage>104588</fpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2019.104588</pub-id>
  <?supplied-pmid 31415805?>
  <pub-id pub-id-type="pmid">31415805</pub-id>
 </element-citation>
</ref>
